ROCK2 inhibition triggers the collective invasion of colorectal adenocarcinomas
Fotine Libanje(Inserm), Fanny Jaulin(Inserm), David Malka(Inserm), Friedrich Prall(University of Rostock), Maximiliano Gelli(Université Paris-Saclay), Valérie Boige(Inserm), Rui Luan(Inserm), Diane Goèré(Assistance Publique – Hôpitaux de Paris), Peggy Dartigues(Institut Gustave Roussy), Joël Raingeaud(Inserm), Olivier Zajac(Inserm), Laëtitia Marisa(La Ligue Contre le Cancer), Jean-Yves Soazec(Institut Gustave Roussy), Zoé ap Thomas(Inserm), Joel Paulo Russomano Veiga(Memorial Sloan Kettering Cancer Center), Alan Hall(MRC Laboratory for Molecular Cell Biology), Julien Adam(Inserm)
Cited by 60
Related Papers
RHO GTPASES: Biochemistry and Biology
|Annual Review of Cell and Developmental Biology|2005|3k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine
|Journal of Biological Chemistry|1995|2.2k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k